IL33 and Alzheimer disease: In 2016, Galand et al. [42] demonstrated that IL-33 is released following mechanical skin injury, enhances IgE-mediated mast cell degranulation, and promotes oral anaphylaxis following epicutaneous sensitization in AD murine models.